Penn Transplant Institute

Pancreas Transplant at Penn Transplant Institute

The Penn Transplant Institute was the first program in the region to offer pancreas transplant as treatment for type 1 diabetes. Pancreas transplantation is the most complete treatment currently available to maintain blood sugar control for patients with type 1 diabetes. While not as common as the transplant of other organs, pancreas transplant offers patients the potential for an insulin-free life.

Islets are a group of cells that produce insulin and are found primarily in the pancreas. These insulin-producing cells are destroyed by type 1 diabetes. Islet cell transplantation is an experimental procedure that transplants islets cells from a donor pancreas into the liver of patients with type 1 diabetes. If the transplant is successful, the new islets begin producing insulin.

Penn Transplant Institute is one of the leading transplant centers in the world researching islet cell transplantation. As a member of the Clinical Islet Transplantation Consortium funded by the National Institutes of Health, Penn offers a number of clinical trials for islet transplantation.

There are several options for pancreas transplant including: simultaneous kidney and pancreas transplant (SPK), pancreas after kidney transplant (PAK) and pancreas alone transplant (PAT).

Register for the 2015 Donor Dash

Join Team PENN MEDICINE

on Sunday, April 19, 2015

Register Here